Literature DB >> 22117613

Redox regulation of p53, redox effectors regulated by p53: a subtle balance.

Agnès Maillet1, Shazib Pervaiz.   

Abstract

SIGNIFICANCE: Reactive oxygen species (ROS), generated by cells as side products of biological reactions, function as secondary messengers by impacting a host of cellular networks involved in maintaining normal homeostatic growth as well as pathological disease states. Redox-sensitive proteins, such as the tumor suppressor protein p53, are susceptible to ROS-dependent modifications, which could impact their activities and/or biological functions. RECENT ADVANCES: p53 is a transcription factor that controls a wide variety of target genes and regulates numerous cellular functions in response to stresses that lead to genomic instability. Thus, redox modifications of p53 could impact cell fate signaling and could have profound effects on pathways fundamental to maintaining cell and tissue integrity. CRITICAL ISSUES: Recent studies present evidence that ROS function upstream of p53 in some model systems, while in others ROS production could be a downstream effect of p53 activation. FUTURE DIRECTIONS: In this review, we describe how ROS production regulates p53 activity and how p53 can, in turn, influence cellular ROS production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22117613     DOI: 10.1089/ars.2011.4434

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  63 in total

Review 1.  Reactive oxygen species: the achilles' heel of cancer cells?

Authors:  Xiaojiang Cui
Journal:  Antioxid Redox Signal       Date:  2012-03-02       Impact factor: 8.401

2.  Disruption of the ribosomal P complex leads to stress-induced autophagy.

Authors:  Ana Artero-Castro; Mileidys Perez-Alea; Andrea Feliciano; Jose A Leal; Mónica Genestar; Josep Castellvi; Vicente Peg; Santiago Ramón Y Cajal; Matilde E L Lleonart
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 3.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

Review 4.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

Review 5.  Oxidative Stress in Cancer.

Authors:  John D Hayes; Albena T Dinkova-Kostova; Kenneth D Tew
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

6.  TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.

Authors:  Jeffrey S Murley; Richard C Miller; Ralph R Weichselbaum; David J Grdina
Journal:  Radiat Res       Date:  2017-08-16       Impact factor: 2.841

7.  The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.

Authors:  Megan Romeo; Tetiana Hutchison; Aditi Malu; Averi White; Janice Kim; Rachel Gardner; Katie Smith; Katherine Nelson; Rachel Bergeson; Ryan McKee; Carolyn Harrod; Lee Ratner; Bernhard Lüscher; Ernest Martinez; Robert Harrod
Journal:  Virology       Date:  2018-02-20       Impact factor: 3.616

8.  Inhibition of glutathione synthesis distinctly alters mitochondrial and cytosolic redox poise.

Authors:  Vladimir L Kolossov; William P Hanafin; Jessica N Beaudoin; Denisa E Bica; Stephen J DiLiberto; Paul J A Kenis; H Rex Gaskins
Journal:  Exp Biol Med (Maywood)       Date:  2014-02-28

9.  A novel link between p53 and ROS.

Authors:  Zhaoyue He; Hans-Uwe Simon
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.

Authors:  Ameya Paranjpe; Kalkunte S Srivenugopal
Journal:  Carcinogenesis       Date:  2013-01-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.